{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:39:13Z","timestamp":1792485553060,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014109","name":"Baylor Scott & White Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ophtha.2026.07.036","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T05:56:47Z","timestamp":1785995807000},"page":"1296-1305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cup-To-Disc Ratio in Glucagon-Like Peptide 1 Receptor Agonist-Associated Nonarteritic Anterior Ischemic Optic Neuropathy"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3422-8994","authenticated-orcid":false,"given":"Christian M.","family":"Robertson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrick S.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9121-5178","authenticated-orcid":false,"given":"Kevin E.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6787-8722","authenticated-orcid":false,"given":"Ridhima R.","family":"Guniganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Joseph F.","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5669-9435","authenticated-orcid":false,"given":"Kenneth C.","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2026.07.036_bib1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00041327-199403000-00011","article-title":"Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California","volume":"14","author":"Johnson","year":"1994","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.036_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9394(14)70999-7","article-title":"Incidence of nonarteritic anterior ischemic optic neuropathy","volume":"123","author":"Hattenhauer","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.036_bib3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/bjophthalmol-2017-311140","article-title":"Prevalence and incidence of non-arteritic anterior ischaemic optic neuropathy in South Korea: a nationwide population-based study","volume":"102","author":"Lee","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.036_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/WNO.0000000000002102","article-title":"Reexamining the incidence of nonarteritic anterior ischemic optic neuropathy: a Rochester Epidemiology Project study","volume":"44","author":"Foster","year":"2024","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.036_bib5","series-title":"Rocky Mountain Neuro-ophthalmology Society Meeting","author":"Hoyt","year":"1982"},{"key":"10.1016\/j.ophtha.2026.07.036_bib6","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0161-6420(87)33263-4","article-title":"Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis","volume":"94","author":"Beck","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.07.036_bib7","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ophtha.2024.01.011","article-title":"Ophthalmic and systemic factors of acute nonarteritic anterior ischemic optic neuropathy in the Quark207 Treatment Trial","volume":"131","author":"Kupersmith","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.07.036_bib8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0002-9394(14)73478-6","article-title":"Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy","volume":"116","author":"Burde","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.036_bib9","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamaophthalmol.2024.2296","article-title":"Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide","volume":"142","author":"Hathaway","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.036_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ajo.2025.02.025","article-title":"The effect of semaglutide and GLP-1 RAs on risk of nonarteritic anterior ischemic optic neuropathy","volume":"274","author":"Abbass","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.036_bib11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamaophthalmol.2024.6555","article-title":"Semaglutide and nonarteritic anterior ischemic optic neuropathy","volume":"143","author":"Cai","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.036_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ophtha.2024.10.030","article-title":"Association between semaglutide and nonarteritic anterior ischemic optic neuropathy: a multinational population-based study","volume":"132","author":"Chou","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.07.036_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40942-024-00620-x","article-title":"Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes","volume":"10","author":"Grauslund","year":"2024","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.ophtha.2026.07.036_bib14","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1001\/jamaophthalmol.2025.0349","article-title":"Semaglutide and nonarteritic anterior ischemic optic neuropathy risk among patients with diabetes","volume":"143","author":"Hsu","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.036_bib15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ajo.2025.05.007","article-title":"Association of glucagon-like peptide-1 receptor agonists with optic nerve and retinal adverse events: a population-based observational study across 180 countries","volume":"277","author":"Lakhani","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.036_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/14740338.2024.2419989","article-title":"Ocular adverse events associated with GLP-1 receptor agonists: a real-world study based on the FAERS database and network pharmacology","volume":"24","author":"Luo","year":"2025","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.ophtha.2026.07.036_bib17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/jamaophthalmol.2025.2489","article-title":"Ocular adverse events with semaglutide: a systematic review and meta-analysis","volume":"143","author":"Natividade","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.036_bib18","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1111\/dom.16316","article-title":"Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: a Danish-Norwegian cohort study","volume":"27","author":"Simonsen","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ophtha.2026.07.036_bib19","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/dom.70200","article-title":"GLP-1RA and the risk of non-arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes: a population-based study","volume":"28","author":"Tesfaye","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ophtha.2026.07.036_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.26321","article-title":"GLP-1 receptor agonists and sight-threatening ophthalmic complications in patients with type 2 diabetes","volume":"8","author":"Ramsey","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ophtha.2026.07.036_bib21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.26327","article-title":"Semaglutide or tirzepatide and optic nerve and visual pathway disorders in type 2 diabetes","volume":"8","author":"Wang","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ophtha.2026.07.036_bib22","article-title":"Does semaglutide increase the risk of non-arteritic anterior ischemic optic neuropathy? A systematic review and meta-analysis of emerging evidence","volume":"15","author":"Chen","year":"2025","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.ophtha.2026.07.036_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jamaophthalmol.2025.6262","article-title":"New-onset nonarteritic anterior ischemic optic neuropathy and initiators of semaglutide in US veterans with type 2 diabetes","volume":"144","author":"Heberer","year":"2026","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.036_bib24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/jamaophthalmol.2025.2299","article-title":"GLP-1 RAs and risk of nonarteritic anterior ischemic optic neuropathy in older patients with diabetes","volume":"143","author":"Fung","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.036_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12886-025-03958-4","article-title":"Anterior ischemic optic neuropathy in patients treated with semaglutide: report of four cases with a possible association","volume":"25","author":"Ahmadi","year":"2025","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.07.036_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jamaophthalmol.2024.6058","article-title":"Ophthalmic complications associated with the antidiabetic drugs semaglutide and tirzepatide","volume":"143","author":"Katz","year":"2025","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2026.07.036_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/reports8030149","article-title":"Is semaglutide linked to NAION? A case report on a rare ocular complication","volume":"8","author":"Le\u0161in Ga\u0107ina","year":"2025","journal-title":"Reports (MDPI)"},{"key":"10.1016\/j.ophtha.2026.07.036_bib29","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/dom.16076","article-title":"Glucagon-like peptide 1 (GLP1) receptor agonists and risk for ischemic optic neuropathy: a meta-analysis of randomised controlled trials","volume":"27","author":"Silverii","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ophtha.2026.07.036_bib30","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/eye.2017.50","article-title":"A comparison of cup-to-disc ratio estimates by fundus biomicroscopy and stereoscopic optic disc photography in the Tema Eye Survey","volume":"31","author":"Mwanza","year":"2017","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2026.07.036_bib31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/IJG.0000000000000155","article-title":"Cup-to-disc ratio from Heidelberg retina tomograph 3 and high-definition optical coherence tomography agrees poorly with clinical assessment","volume":"25","author":"Perera","year":"2016","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2026.07.036_bib32","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.ophtha.2010.12.008","article-title":"Comparison of automated analysis of Cirrus HD OCT spectral-domain optical coherence tomography with stereo photographs of the optic disc","volume":"118","author":"Sharma","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.07.036_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajo.2023.03.013","article-title":"Race distribution in nonarteritic anterior ischemic optic neuropathy","volume":"253","author":"Banc","year":"2023","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026005415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026005415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:56:58Z","timestamp":1792483018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642026005415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0161642026005415"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.07.036","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cup-To-Disc Ratio in Glucagon-Like Peptide 1 Receptor Agonist-Associated Nonarteritic Anterior Ischemic Optic Neuropathy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.07.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}